Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07326631 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 8, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To assess the effect of Finerinone on slowing renal function decline and improving cardiovascular outcomes, particularly heart failure risk, in patients with diabetic CKD.
Trial Details
NCT Number NCT07326631
Lead Sponsor College of Physicians and Surgeons Pakistan
Conditions
(from sponsor)		 Diabetic Kidney Disease (DKD), Heart Failure
Related terms Diabetic Nephropathies, Heart Failure
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov